Operating Lease, Right-of-Use Asset of NextCure, Inc. from 31 Dec 2022 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
NextCure, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2022 to 30 Sep 2025.
  • NextCure, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $2,785,000, a 18% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

NextCure, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $2,785,000 -$630,000 -18% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 $2,948,000 -$613,000 -17% 30 Jun 2025 10-Q 07 Aug 2025 2025 Q2
Q1 2025 $3,108,000 -$524,000 -14% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $3,263,000 -$1,135,000 -26% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 $3,415,000 -$1,142,000 -25% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 $3,561,000 -$1,151,000 -24% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $3,632,000 -$1,233,000 -25% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $4,398,000 -$618,000 -12% 31 Dec 2023 10-K 06 Mar 2025 2024 FY
Q3 2023 $4,557,000 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $4,712,000 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $4,865,000 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $5,016,000 31 Dec 2022 10-K 21 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.